Header links
Intranet
Donar
image/svg+xml Mapa
Contacto

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic F

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Abierta
  • Código protocolo: VX18-445-110
  • Código EudraCT: 2019-000833-37
  • Grupo de investigación: Neumología
  • Servicio: Neumología
  • Investigador/a principal:  Álvarez Fernandez, Antonio
  • Fase: Fase III
  • Estado: Reclutando voluntarios